Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spero Therapeutics (SPRO) Change in Taxes (2023 - 2024)

Historic Change in Taxes for Spero Therapeutics (SPRO) over the last 2 years, with Q4 2024 value amounting to $77000.0.

  • Spero Therapeutics' Change in Taxes rose 10422.15% to $77000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year change of. This contributed to the annual value of -$213000.0 for FY2024, which is 15503.88% down from last year.
  • As of Q4 2024, Spero Therapeutics' Change in Taxes stood at $77000.0, which was up 10422.15% from -$290000.0 recorded in Q3 2024.
  • In the past 5 years, Spero Therapeutics' Change in Taxes registered a high of $77000.0 during Q4 2024, and its lowest value of -$1.8 million during Q4 2023.